Kornitzer Capital Management Inc. KS Purchases 9,114 Shares of Xylem Inc. (NYSE:XYL)

Kornitzer Capital Management Inc. KS lifted its position in shares of Xylem Inc. (NYSE:XYLFree Report) by 9.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 109,882 shares of the industrial products company’s stock after purchasing an additional 9,114 shares during the period. Kornitzer Capital Management Inc. KS’s holdings in Xylem were worth $12,566,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently made changes to their positions in XYL. First Trust Advisors LP increased its stake in shares of Xylem by 399.3% during the first quarter. First Trust Advisors LP now owns 2,951,349 shares of the industrial products company’s stock worth $251,632,000 after purchasing an additional 2,360,214 shares during the period. Morgan Stanley grew its position in Xylem by 145.5% during the fourth quarter. Morgan Stanley now owns 3,731,215 shares of the industrial products company’s stock worth $412,561,000 after buying an additional 2,211,083 shares in the last quarter. Norges Bank acquired a new stake in Xylem during the fourth quarter worth approximately $197,762,000. Vanguard Group Inc. grew its position in Xylem by 7.6% during the first quarter. Vanguard Group Inc. now owns 20,390,911 shares of the industrial products company’s stock worth $1,738,529,000 after buying an additional 1,435,798 shares in the last quarter. Finally, Invesco Ltd. grew its position in Xylem by 53.6% during the first quarter. Invesco Ltd. now owns 3,828,177 shares of the industrial products company’s stock worth $326,390,000 after buying an additional 1,335,241 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.

Insider Buying and Selling

In related news, SVP Franz Cerwinka sold 2,408 shares of the firm’s stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the transaction, the senior vice president now directly owns 11,750 shares of the company’s stock, valued at approximately $1,431,032.50. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the completion of the transaction, the chief accounting officer now directly owns 2,935 shares of the company’s stock, valued at approximately $360,682.15. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Franz Cerwinka sold 2,408 shares of the firm’s stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total value of $293,270.32. Following the transaction, the senior vice president now directly owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The disclosure for this sale can be found here. 0.27% of the stock is owned by corporate insiders.

Xylem Price Performance

Shares of NYSE XYL traded up $0.68 during mid-day trading on Friday, hitting $127.84. 2,250,015 shares of the stock traded hands, compared to its average volume of 921,680. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.76 and a quick ratio of 1.30. Xylem Inc. has a twelve month low of $87.59 and a twelve month high of $130.86. The company has a market cap of $30.99 billion, a PE ratio of 47.00, a price-to-earnings-growth ratio of 2.53 and a beta of 1.10. The firm has a 50 day simple moving average of $127.01 and a two-hundred day simple moving average of $112.36.

Xylem (NYSE:XYLGet Free Report) last released its quarterly earnings data on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.03. Xylem had a return on equity of 9.65% and a net margin of 8.27%. The company had revenue of $2.12 billion for the quarter, compared to the consensus estimate of $2.05 billion. During the same quarter last year, the business posted $0.92 EPS. Xylem’s revenue for the quarter was up 40.6% on a year-over-year basis. As a group, equities research analysts forecast that Xylem Inc. will post 4.13 EPS for the current fiscal year.

Xylem Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 20th. Investors of record on Wednesday, February 21st were given a dividend of $0.36 per share. This is a positive change from Xylem’s previous quarterly dividend of $0.33. This represents a $1.44 annualized dividend and a yield of 1.13%. The ex-dividend date was Tuesday, February 20th. Xylem’s dividend payout ratio (DPR) is currently 52.94%.

Wall Street Analysts Forecast Growth

XYL has been the topic of a number of analyst reports. BNP Paribas initiated coverage on Xylem in a research report on Tuesday, March 12th. They set an “outperform” rating and a $150.00 price target on the stock. Stifel Nicolaus increased their price target on Xylem from $136.00 to $150.00 and gave the stock a “buy” rating in a research report on Wednesday, February 7th. Royal Bank of Canada increased their price target on Xylem from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 7th. Raymond James raised Xylem from an “underperform” rating to a “market perform” rating in a report on Thursday, January 4th. Finally, Citigroup raised their target price on Xylem from $126.00 to $139.00 and gave the company a “neutral” rating in a report on Monday, April 8th. Four analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $138.11.

View Our Latest Stock Analysis on XYL

Xylem Company Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Recommended Stories

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.